Latest Breaking News On - Altus pharmaceuticals - Page 1 : comparemela.com

GenSight Biologics S A : AGM 2024 – Board nominees

GenSight Biologics S A : AGM 2024 – Board nominees
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaFrance generalRhode islandProvidence collegeSaint antoineGensight biologicsMereo biopharmaMichael wyzgaSanofi genzymeLaurence rodriguezCompanies registryHarvard business schoolCarolina life sciences biomanufacturing forumAltus pharmaceuticals incAudit committee

Capricor Therapeutics (CAPR) Appoints Philip J Gotwals to its Board

Capricor Therapeutics (CAPR) Appoints Philip J Gotwals to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philipj gotwalsLinda marbAlliance management at biogenUniversity of california at berkeleyNovartis institutes for biomedical researchAmherst collegeBusiness developmentMassachusetts institute of technologyHarvard business schoolProgram management at altus pharmaceuticalsUniversity of pennsylvaniaCapricor therapeuticsGlobal headVice presidentNovartis institutesBiomedical research

Capricor Therapeutics Announces Appointment of Philip J Gotwals, Ph D to its Board of Directors

24.07.2023 - SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) - Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other . Seite 1

Amherst collegeProgram management at altus pharmaceuticalsUniversity of pennsylvaniaHarvard business schoolAlliance management at biogenBusiness developmentMassachusetts institute of technologyNovartis institutes for biomedical researchUniversity of california at berkeleyGlobal headVice presidentNovartis institutesBiomedical researchProgram managementAltus pharmaceuticalsSenior director

Proteomics Collaborations: A Comprehensive Review (2010-2023) with Access to Headline, Upfront, Milestone & Royalty Data

/PRNewswire/ The "Global Proteomics Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com s offering. The Global.

United statesUnited kingdomBucher biotecAjinomoto aminoscienceCaprotec bioanalyticsAstellas pharmaCaladrius biosciencesAlamar biosciencesAcceleron pharmaBristol myers squibbLaura woodBioeasy diagnosticaAmarantus biosciencesBayer cropscienceBionova cientificaBoehringer ingelheim vetmedica

Danbury s MannnKind Corp names new chief operating officer - Westfair Communications

MannKind Corp. (NASDAQ: MNKD), a Danbury-based company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, has named Lauren Sabella as executive vice president and chief operating officer.

Lauren sabellaAcorda therapeuticsMannkind corpAltus pharmaceuticals